About
Antibody Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
932
By Phase
PHASE1: 4
By Status
RECRUITING: 2NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06223256Lead Sponsor
A Study of NBL-028 in Patients With Advanced Solid Tumors
PHASE1Recruiting
270 participants
Started: Mar 8, 2024 · Completed: Jan 31, 2027
NCT05877924Lead Sponsor
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
PHASE1Recruiting
200 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2026
NCT05153096Lead Sponsor
Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors
PHASE1Not yet recruiting
410 participants
Started: Apr 30, 2022 · Completed: Dec 31, 2025
NCT05259189Lead Sponsor
A Study of NBL-012 in Healthy Chinese Subjects
PHASE1Completed
52 participants
Started: Jul 1, 2021 · Completed: May 23, 2022
Locations (1)
Headquarters
Ewing, NJ, United States
Map
Loading map...